Search research articles
Contact Us
Filters
Showing results (41-50 of 150) with videos related to
Page
of 15
Sort By:
Revue D'Electroencephalographie Et De Neurophysiologie Clinique
|
November 1, 1982
[Electroencephalographic surveillance during carotid endarterectomy]
C Blondeau, F Hebert, G Ducasble, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours
K Szepeshazi, A V Schally, K Groot, et al.
Clinical Pharmacology and Therapeutics
|
May 12, 2026
Effect of Late Second to Early Third Trimester of Pregnancy on the Activity of Renal Organic Anion Transporters (OAT1 and OAT3): A Biomarker Study
Aarzoo Thakur, Jashvant D Unadkat, Emily E Fay, et al.
Journal of Clinical Pharmacology
|
February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers
M F Hebert, R M Fisher, C L Marsh, et al.
Scientific Reports
|
April 27, 2017
Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
Weibin Zha, Horace T B Ho, Tao Hu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
H Kiaris, A V Schally, A Nagy, et al.
Pharmacotherapy
|
April 6, 2023
Renal function estimating equations performance during pregnancy and postpartum
Dina E Zaghloul, Rachel Ryu, Bryan Kestenbaum, et al.
Reproductive, Female and Child Health
|
May 7, 2025
A Pilot Evaluation of the Adequacy of Prenatal Vitamins to Cover Dietary Deficits During Pregnancy and Lactation
Chase K Smith, Emily E Fay, Sue L Moreni, et al.
Cancer Letters
|
August 4, 2001
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix
I Chatzistamou, A V Schally, K Szepeshazi, et al.
Journal of Clinical Pharmacology
|
December 19, 2003
Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers
Mary F Hebert, Jeong M Park, Yu-Luan Chen, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 150) with videos related to
Sort By:
Page
of 15
Revue D'Electroencephalographie Et De Neurophysiologie Clinique
|
November 1, 1982
[Electroencephalographic surveillance during carotid endarterectomy]
C Blondeau, F Hebert, G Ducasble, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours
K Szepeshazi, A V Schally, K Groot, et al.
Clinical Pharmacology and Therapeutics
|
May 12, 2026
Effect of Late Second to Early Third Trimester of Pregnancy on the Activity of Renal Organic Anion Transporters (OAT1 and OAT3): A Biomarker Study
Aarzoo Thakur, Jashvant D Unadkat, Emily E Fay, et al.
Journal of Clinical Pharmacology
|
February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers
M F Hebert, R M Fisher, C L Marsh, et al.
Scientific Reports
|
April 27, 2017
Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
Weibin Zha, Horace T B Ho, Tao Hu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
H Kiaris, A V Schally, A Nagy, et al.
Pharmacotherapy
|
April 6, 2023
Renal function estimating equations performance during pregnancy and postpartum
Dina E Zaghloul, Rachel Ryu, Bryan Kestenbaum, et al.
Reproductive, Female and Child Health
|
May 7, 2025
A Pilot Evaluation of the Adequacy of Prenatal Vitamins to Cover Dietary Deficits During Pregnancy and Lactation
Chase K Smith, Emily E Fay, Sue L Moreni, et al.
Cancer Letters
|
August 4, 2001
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix
I Chatzistamou, A V Schally, K Szepeshazi, et al.
Journal of Clinical Pharmacology
|
December 19, 2003
Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers
Mary F Hebert, Jeong M Park, Yu-Luan Chen, et al.
Page
of 15